Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

N-Boc-N'-Nitro-L-Arginine

    • Product Name N-Boc-N'-Nitro-L-Arginine
    • Alias Boc-NO2-Arg
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    916214

    Compound Name N-Boc-N'-Nitro-L-Arginine
    Chemical Formula C11H20N4O6
    Molecular Weight 304.30 g/mol
    Cas Number 214030-43-2
    Appearance White to off-white powder
    Purity Typically ≥98%
    Solubility Soluble in DMSO, methanol; slightly soluble in water
    Storage Temperature -20°C (desiccated)
    Synonyms N-Boc-N'-Nitro-L-arginine, N-tert-Butoxycarbonyl-N'-Nitro-L-Arginine
    Iupac Name tert-butyl (2S)-2-[(nitroamino)iminomethyl]-4-(methylamino)butanoate
    Smiles CC(C)(C)OC(=O)[C@@H](CCCN=[N+](O-)O)N

    As an accredited N-Boc-N'-Nitro-L-Arginine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing N-Boc-N'-Nitro-L-Arginine is packaged in a sealed amber glass bottle, 1g quantity, labeled with product details and hazard information.
    Shipping **Shipping Description for N-Boc-N'-Nitro-L-Arginine:** N-Boc-N'-Nitro-L-Arginine is shipped in tightly sealed containers to protect it from moisture and light. It is transported under ambient conditions unless otherwise specified, following all chemical safety regulations. Proper labeling and relevant hazard information are provided to ensure safe handling and compliance during transit.
    Storage N-Boc-N'-Nitro-L-Arginine should be stored in a cool, dry, and well-ventilated area, away from sources of heat and ignition. Keep the container tightly closed and protected from moisture and direct sunlight. Store the chemical in a designated area for nitro compounds, separated from incompatible substances such as strong acids, bases, and oxidizers. Use appropriate, labeled containers and avoid physical damage.
    Application of N-Boc-N'-Nitro-L-Arginine

    Applications of N-Boc-N'-Nitro-L-Arginine in Industrial Manufacturing

    N-Boc-N'-Nitro-L-Arginine has become a critical intermediate in multiple segments of the fine chemical and pharmaceutical industries. Our manufacturing clients use it to support peptide synthesis, design of nitric oxide synthase inhibitors, and as a specialty building block for complex molecular development. The following scenarios highlight real-world downstream applications where this material proves indispensable to industrial processes.

    1. Peptide Active Pharmaceutical Ingredient (API) Manufacturing

    This protected nitro-arginine derivative plays a specific role in the solid-phase peptide synthesis workflow, allowing for the targeted introduction of modified arginine residues into research and commercial peptide APIs. Pharmaceutical companies rely on its unique functional groups to construct analogues that investigate biological targets, including enzyme inhibition and receptor modulation, demonstrating effectiveness in experimental therapeutics development.

    Industry compliance standards

    • ICH Q7 GMP Guidelines
    • European Pharmacopoeia (Ph. Eur.)
    • USP <791> pH Quality Testing
    • FDA 21 CFR Part 211 cGMP

    Typical usage ratio

    • 0.5–2.0 molar equivalents per modified residue, depending on target sequence complexity and resin loading

    Downstream process integration

    • Direct coupling during chain elongation phase of Fmoc- or Boc-based solid-phase peptide synthesis followed by selective deprotection under mild acidic conditions

    Final product types

    • Peptide-based APIs for clinical trial materials and pre-commercial supply
    • Custom peptide analogues for pharmacological studies
    • Peptide research reagents

    2. Precursor in Nitric Oxide Synthase (NOS) Inhibitor Development

    This compound acts as a protected intermediate for the preparation of nitroarginine analogues, serving pharmaceutical R&D teams in the pathway of NOS inhibitor lead optimization. When incorporated into higher-stage synthesis, it enables well-controlled modifications on the guanidino group, allowing researchers to develop specialized small molecules that regulate NO production—essential for cardiovascular, neurodegenerative, and inflammatory disorder projects.

    Industry compliance standards

    • OECD Good Laboratory Practice (GLP)
    • ISO/IEC 17025 Analytical Method Validation
    • REACH Registration (for intermediate use)
    • ECHA Substances of Very High Concern (SVHC) Notification, where applicable

    Typical usage ratio

    • Equimolar quantities relative to target intermediate, adjusted by desired functionalization level and purification process yield

    Downstream process integration

    • Introduction in stepwise synthetic routes after activation and coupling, followed by Boc- and nitro-group specific deprotection to yield functionalized arginine derivatives

    Final product types

    • Nitric oxide synthase inhibitor candidates for preclinical research
    • Pharmacokinetic and metabolic markers for drug discovery laboratories
    • Reference standards for analytical chemistry testing

    3. Specialty Amino Acid Derivatives for Peptide Library Construction

    Peptide contract manufacturers use this raw material to introduce nitro-arginine modifications within combinatorial peptide libraries. The protected structure ensures chemical selectivity during parallel synthesis pipelines, supporting high-throughput screening programs in pharmaceutical research and molecular diagnostic tool development, where unique residue patterns extend biological diversity and functionalization.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems
    • ICH Q11 API Manufacture – Development and Manufacture of Drug Substances
    • US Pharmacopeia General Chapter <1058> Analytical Instrument Qualification
    • Japanese Pharmacopoeia (JP) peptide standards

    Typical usage ratio

    • 0.2–1.5 mmol per peptide, customized by library diversity requirements and sequence length

    Downstream process integration

    • Chemically incorporated into solid or solution-phase synthesis cycles at predetermined positions as part of automated or semi-automated peptide library assembly

    Final product types

    • Custom peptide libraries for drug target identification
    • Diagnostic screening panels
    • Protein interaction mapping reagents

    4. Building Block in Imaging Probe Synthesis

    N-Boc-N'-Nitro-L-Arginine is utilized by manufacturers of imaging agents as a specialty building block for conjugating nitro-guanidino groups onto peptide or protein carriers. This enables downstream producers to develop probes for research in nitric oxide–related cellular processes and in vivo diagnostic assays, relying on heavily controlled conjugation and purification processes to meet labeling standards.

    Industry compliance standards

    • ISO 13485:2016 Medical Devices – Quality Management Systems
    • FDA 21 CFR Part 820 (for devices)
    • EU In Vitro Diagnostic Regulation (IVDR) 2017/746
    • USP <1030> Biological Assay Validation

    Typical usage ratio

    • Typically 0.8–1.2 equivalents per labelling reaction, with adjustments based on peptide/protein length and label density requirements

    Downstream process integration

    • Coupling onto side chains of precursor peptides or proteins during the probe assembly step; deprotection and purification steps tightly controlled to prevent cross-contamination and retain functional integrity

    Final product types

    • Peptide-based imaging probes
    • In vitro diagnostic test reagents
    • Cellular uptake marker conjugates
    Free Quote

    Competitive N-Boc-N'-Nitro-L-Arginine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N-Boc-N'-Nitro-L-Arginine: A Chemist’s Perspective from the Manufacturer’s Floor

    Bringing Real-World Precision to the Research Bench

    In our line of work, products like N-Boc-N'-Nitro-L-Arginine—sometimes called Boc-NO2-L-Arginine—do not just fill an order form. Every batch that leaves our facility holds the result of careful synthesis, process control, and a commitment to consistency. Over the years, our focus has remained steady: deliver N-Boc-N'-Nitro-L-Arginine with a purity that research chemists expect, without deviations batch to batch. We have seen the chemistry landscape push for increased specificity, driving the demand for protected amino acid derivatives with functionalized side chains. This compound illustrates that core demand—fine-tuned molecular design with blocking and reactive groups for versatile downstream applications.

    The Story Behind the Molecule: Form, Structure, and Application

    N-Boc-N'-Nitro-L-Arginine offers a scaffold carrying a tert-butyloxycarbonyl (Boc) protection at the α-amino group and a nitro moiety on the terminal guanidino group. The model we produce here emphasizes a single well-documented isomer, delivered as a free-flowing off-white powder free from hydrolysis byproducts. For any researcher working in NO synthase inhibition, this molecule stands apart from standard arginine derivatives. The Boc-group gives selective deprotection capabilities, and the nitro group alters biological activity in distinctive, well-published ways. I have talked to and worked alongside synthetic chemists who rely on these subtleties for peptide design—eliminating side reactions that would otherwise ruin a carefully planned synthetic pathway.

    Why the Boc and Nitro Combination Matters

    N-Boc-N'-Nitro-L-Arginine is not just arginine with a fancy side chain. The Boc group ensures stability under mild acid conditions, lets you protect the amino function through multiple synthetic steps, and removes cleanly when you want it gone—no micro-scrambling or side reactions that would undermine selectivity. The nitro group introduced to the guanidino terminus delivers a tool for modulating function, especially in assays tracking nitric oxide synthesis or signaling. From the manufacturer’s side, handling the nitro group takes skilled operators and tightly monitored chemistry—nitro compounds demand respect for their energetic potential and sensitivity. We rigorously control moisture, temperature, and addition rates through every cycle. Any slip shows up as byproducts in our QC, so our technicians keep their eyes on every stage.

    Quality Control and Batch Integrity: Lessons Learned in Production

    Producing N-Boc-N'-Nitro-L-Arginine presents challenges that go past simple reaction yields. We track impurity loads, color, moisture, and particle size because our customers measure these parameters as soon as the bottle reaches their benchtop. I have been in enough meetings with dissatisfied users of subpar material from less rigorous plants—they notice every botched extraction and every crystal stuck together because of poor drying. In house, our monitoring relies on HPLC, NMR, and elemental analysis. If a batch falls short, we scrap it. The bar does not move. We’ve invested in double filtration, in-line drying, and an isolated clean area for packaging, not because of a marketing bullet point but from listening to what real users experience at the bench.

    Application Focus: NO Synthase Inhibition and Peptide Modification

    N-Boc-N'-Nitro-L-Arginine has carved out a reputation in nitric oxide synthase (NOS) research. Researchers order repeat lots for use as a reversible NOS inhibitor, exploiting the nitro group’s electron-withdrawing effect. The Boc group shields the α-amino when building complex peptide chains—side chain functionalization stays intact until final global deprotection. We know how one failed coupling or premature deprotection can mean lost days and wasted material, so every lot follows tight release criteria. These applications drive heightened demand for traceability and reproducibility. Our process records every operator who touches the line, every vessel used, every analytical run. As someone who has made the mistake of missing a contaminant in precursor materials, I know what is at stake.

    The Differences: Beyond Standard L-Arginine or Mono-protected Analogs

    It is tempting to lump Boc-protected, nitro-functionalized arginine in with dozens of similar amino acid derivatives. From a manufacturing and practical standpoint, this is a shortcut that leads to lab failures. Regular L-Arginine, whether supplied as a free base, HCl salt, or simple Boc-protected analogue, does not deliver the same reactive platform. The extra nitro group creates new sites for molecular interaction and enzyme selectivity. Peptide chemists and medicinal chemists come to us for a product that reliably performs in blocked-synthesis contexts or as a tool compound for enzyme studies, knowing that an off-the-shelf arginine simply can’t substitute.

    Mono-protected arginine derivatives offer convenience, but not the combination of controlled Boc deprotection and nitro-tail functionalization. Miss out on either, and the synthetic route can stall. I have seen researchers waste entire research cycles working around issues caused by suboptimal protection chemistry or impure analogs. Our synthesis approach nimbly walks the fine line between full protection and selective activation, so that downstream chemistries move smoothly. We take pride in documenting real specification checks, not cut-and-paste vague guarantees.

    Manufacturing Realities: Instruments, People, and the Unseen Details

    Large-scale production of N-Boc-N'-Nitro-L-Arginine does not just come from a lone flask on a bench. Every kilogram reflects a network of reactors, pumps, skilled chemists, and robust supply chains for specialized reagents. Technical managers here prize reliable sourcing—one off-spec drum of Boc-anhydride or nitric reagent cascades into days lost and a full cleaning cycle for glassware and piping. Our staff trains to recognize off-odors and color changes in process solutions, learned from years in the plant and transferred person-to-person.

    During each scale-up campaign, the operations team holds daily standups to review crystal habit, cake wash protocols, and drying performance. We tinker with filtration rates, adjust grain size by modifying cooling profiles, and keep air and solvent lines spotless. Forget any single step, and the lot can fail moisture or solvent residual checks—meaning it never sees the shipping line. Seeing every delivery leave the dock with a signed-off batch record feels rewarding, but it took years of trial-and-error to reach our track record.

    User Feedback: Real-World Demands Shape Our Process

    Batch reviews do not end in our own QC department. End-user experience feeds right back into process adjustments. Some of our earliest customers reported issues with flocculent powders that clumped on opening. Their feedback led us to refine drying techniques and optimize powder morphology for better handling and mixing. Analytical chemists asked for tighter bounds on heavy metal and phosphate impurity ranges. They weren’t looking for abstract guarantees—they needed every trace species measured, every lot signed off with clear numbers on the COA.

    Peptide chemists stressed the way some suppliers ship products with inconsistent mass spectra. That inconsistency turns project timelines upside-down. Real stories from researchers who lost days troubleshooting a single impurity turned us into sticklers for batch homogeneity and robust QC signoff. In this business, dialogue from the bench to the plant floor shapes every process tweak.

    Comparing N-Boc-N'-Nitro-L-Arginine to Other NG or NO Analogs

    The world of functionalized arginine is not small. NG-methyl, NG-nitro, and NO-protected derivatives each offer a specific tool for biological and synthetic chemists. Yet the dual protection and modification of N-Boc-N'-Nitro-L-Arginine puts it in a unique position. NG-methyl-L-arginine can inhibit some enzyme systems, but the Boc-protection and nitro combination offers enhanced selectivity and staged deprotection strategies, which many synthetic plans demand. Unlike simpler NO2-L-arginine salts, our offering holds stability through multi-step peptide assembly—no premature hydrolysis, no accidental deprotection.

    That extra layer of control might seem niche, but as users push the frontier of NO synthase studies or peptide probe design, you want tools that perform the same way every time. We hear from researchers building structure-activity relationship libraries who tried to shortcut the process with cheaper mono-protected variants. It rarely goes well. The need to tune both the backbone and the side chain groups is more critical than ever, as targets get more complicated and analytical tools get more sensitive.

    Specifications Matter: Purity, Storage, and Performance

    Real product performance in the hands of researchers comes down to the fine details: purity, stability, and real-world handling. Every lot of N-Boc-N'-Nitro-L-Arginine we make is checked for purity above 98% by HPLC, with additional NMR and MS confirmation to document structure. We store it at 2 to 8°C in a low-humidity, argon-flushed vault to prevent hydrolysis or nitro reduction. Every container is welded shut with tamper-evident strips and triple-wrapped against ambient moisture seepage. Not every lab has full cold-chain management, so we build redundancy into packaging and monitor for dry ice melt or thermal spikes in transit.

    The long-term user feedback on shelf stability confirms our approach—years after shipping, vials pulled from storage retain labeled purity, so experiments can restart after a pause without compromised material. The small investment in over-engineered storage pays off as soon as a research group pulls a two-year-old sample for exploratory work and finds it still crystalline and potent.

    Anticipating the Trends: From Peptide Chemistry to Biological Studies

    The way N-Boc-N'-Nitro-L-Arginine gets used keeps evolving. Ten years ago, orders came mostly from organic chemists working through stepwise peptide synthesis or NO-related enzyme studies. Now biologists, pharmacologists, and even immunologists investigate analogs of L-arginine for their downstream effects on signaling, modulation, and inhibition. Each field brings its own requirements: some need bulk single-use lots, others demand freezer-stable microvials. We stay plugged into the community by talking with users—each year brings new requests for tighter impurity specs, better documentation, and expanded certificate details.

    We have responded with more granular testing—screening for trace solvents, optical rotation checks, and expanded reporting for genotoxic impurities in line with new regulatory demands. Users explore more sophisticated downstream chemistry, so we keep expanding analytical support to match. By staying close to the shifting needs in academia and industry, we learn which nitro protection strategies hit the mark and which don’t.

    Solutions to Common Challenges: What Experience Has Taught Us

    Early in our production, occasional wet cake batches or off-color crystals taught us how little room for error high-purity chemistry allows. Each breakdown pointed to a weak link, whether residual water from poor solvent swaps, or a miscalibration in pH tracking. By overhauling solvent handling and tripling in-line moisture checks, we solved most issues before they left the crystallization vessel. Each setback inspired new process controls—like automated vessel purges with dry nitrogen or micro-filtered transfer lines—for consistent material every time.

    End users flagged inconsistencies when bedding agents or anti-caking compounds found their way into final product. We went the other way—pruning out unnecessary additives for peace of mind and clean mass spectra. Years of handling user complaints about ambiguous documentation pointed us toward more robust, data-backed reporting.

    For transport, nitro compounds can pose unique challenges. We have worked with logistics partners to maintain unbroken cold chains, track every shipment, and proactively replace any box flagged for a temperature deviation. Not all manufacturers commit these resources, but we have seen what happens to sensitive materials exposed to a summer warehouse or delayed customs check. The cost of one compromised shipment outstrips the investment in modern logistics.

    Transparency and Traceability: From Raw Material to Final Product

    Researchers today demand more than just a sealed vial. They want confidence—proof that raw materials do not hide unwanted metals, proof that batch-to-batch impurity profiles match, proof that every lot’s origin and processing history is on file. From sourcing pharmaceutical-grade feedstocks to logging every stirring time, our operation does not lose track of a single gram. Every batch’s journey from raw precursor to final vial leaves a complete digital trail. Auditors, clients, and regulators get full access on demand.

    The underlying value is trust. When a researcher orders from a manufacturer, what they want is assurance—no last-minute surprises, no guesswork in planning their next step. Technical stewardship, drawn from years of hands-on experience, forms the backbone of a lasting relationship between laboratory and plant.

    Looking Forward: The Future of N-Boc-N'-Nitro-L-Arginine

    Where does N-Boc-N'-Nitro-L-Arginine go next? Across the industry, synthetic chemists keep pushing for protection strategies that can handle ever more delicate and complex molecules. Next-generation applications may stretch the demands for even higher purities, new polymorphs, or site-specific labelling. We gear up for these requests with an expanded plant filled with modern instrumentation and ongoing operator training.

    We know some challenges never go away—nitro chemistry always holds an edge of risk, regulatory environments keep evolving, and end-use applications continually innovate. What does not change is the work ethic on the plant floor, the pride in every batch that passes final QC, and the knowledge that real scientists rely on those vials for discoveries at the edge of what chemistry can do.